All week long (Feb 6th to 10th), Christian Homsy, CEO of Celyad, talked about Celyad on Antipode Radio at 8:45am. He answered the questions of Etienne Baffrey about the vision and strategy of the Company for the development of its immunotherapy for cancer treatment.

Listen to the Celyad podcasts! - mp3 format (in French only)

 

"Antipode, le réseau radio du Brabant Wallon"

About Celyad

Developing breakthrough pioneering therapies for life-threatening diseases.

Celyad is a biopharmaceutical company, specialized in cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis. Our scientific approach is inspired by the natural mechanisms that are used by the body to fight disease.

Read more about Celyad

Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial

Next News

Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial